CHIKUNGUNYA VIRUS INFECTION
Clinical trials for CHIKUNGUNYA VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHIKUNGUNYA VIRUS INFECTION trials appear
Sign up with your email to follow new studies for CHIKUNGUNYA VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test nanoparticle vaccine against painful mosquito virus
⭐️ VACCINE ⭐️ Not yet recruitingThis is a first-in-human study to check the safety and immune response of a new experimental vaccine against chikungunya virus. The trial will enroll 40 healthy adults aged 18-60 who will receive two injections six weeks apart. Researchers will closely monitor participants for si…
Matched conditions: CHIKUNGUNYA VIRUS INFECTION
Phase: EARLY_PHASE1 • Sponsor: Gylden Pharma Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 12, 2026 13:50 UTC
-
Plasma from survivors could shield babies from virus brain damage
Disease control Not yet recruitingThis study tests if giving newborns a transfusion of plasma (the liquid part of blood) from people who recently recovered from chikungunya can prevent serious brain inflammation. It focuses on babies whose mothers caught the virus around the time of birth. Researchers will compar…
Matched conditions: CHIKUNGUNYA VIRUS INFECTION
Phase: NA • Sponsor: Centre Hospitalier Universitaire de la Réunion • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC
-
Scientists track pregnancy outcomes after new virus vaccine
Knowledge-focused Not yet recruitingThis study aims to understand the safety of a chikungunya virus vaccine for pregnant women and their babies. Researchers will observe 200 women in Brazil who received the vaccine during or just before pregnancy, comparing their health outcomes to women who received other routine …
Matched conditions: CHIKUNGUNYA VIRUS INFECTION
Sponsor: Valneva Austria GmbH • Aim: Knowledge-focused
Last updated Apr 02, 2026 05:40 UTC